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Aims: Alcohol has deleterious inﬂuences on glucose metabolism which may contribute to the development of
type 2 diabetes mellitus (T2DM). Insulin-like growth factor I (IGF-I) and growth hormone (GH), which interact
with insulin to modulate metabolic control, have been shown to be related to impaired glucose tolerance. This
study was conducted to assess the possibility that altered circulating IGF-I and GH levels contribute to the exac-
erbation of T2DM by alcohol use in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats and non-
diabetic Long-Evans Tokushima Otsuka (LETO) rats.
Main method: OLETF rats were pair-fed a Lieber-DeCarli Regular Ethanol diet and LETO rats were pair-fed a con-
trol diet for 6 weeks. At 6 weeks, an Intraperitoneal Glucose Tolerance Test (IP-GTT) was performed and IGF-I
and GH levels were evaluated.
Key ﬁndings: Prior to an IP-GTT, OLETF-Ethanol (O-E) group had signiﬁcantly a decrease in the mean glucose
levels compared to OLETF-Control (O-C) group. At 120 min post IP-GTT, the O-E group had signiﬁcantly an in-
crease in the mean glucose levels compared to O-C group. The serum IGF-I levels were signiﬁcantly lower and
the serum GH levels were signiﬁcantly higher in the O-E group than in L-C group.
Signiﬁcance: These results suggest that IGF-I and GH are prominent in deﬁning the risk and development of
T2DM, and may be adversely affected by heavy alcohol use, possibly mediating its diabetogenic effects. Thus,
the overall glucose intolerance in the setting of alcoholism may be attributable to inappropriate alteration of
IGF-I and GH levels.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Impaired glucose tolerance, the major pathogenic feature of type 2
diabetes mellitus (T2DM), seems to be directly inﬂuenced by alcohol
use (Hodge et al., 1993; Risinger and Cunningham, 1992). Several stud-
ies suggest that themechanism behind this associationmay be a combi-
nation of the direct toxic effect of chronic alcohol exposure on the
pancreatic islet cells and decreased suppression of hepatic glucose pro-
duction as a result of impaired insulin action (Holbrook et al., 1990;
Rosengren et al., 1988).
The free circulating insulin-like growth factor-1 (IGF-I) mediates
several important effects of pituitary growth hormone (GH), which
stimulates the synthesis of peripheral IGF-I in the predominant target,Seoul St. Mary's Hospital, The
Banpo-daero, Seocho-gu, Seoul
82 2 594 3870.
c.Open access under CC BY-NC-ND licethe liver, as well as several other tissues including the lung, kidney, thy-
mus, spleen, heart, muscle, and gonads. IGF-I shares 50% amino acid se-
quence homology with insulin, and as a result, elicits almost the same
hypoglycemic response (Boulware et al., 1994). In addition to its insulin
like effects, this growth-promoting peptide inﬂuences peripheral
growth, differentiation, and survival in variety of cells and tissues
(Daughaday and Rotwein, 1989). There is limited evidence that glucose
intolerance in alcohol-dependent patients and insulin resistance in sub-
jects with different degrees of glucose tolerance may be related to dys-
regulation in IGF-I (Sesti et al., 2005; Singh et al., 1988). GH acts by
binding to its receptor (GHR) primarily at two sites, the liver and the
growth plate. GH plays an important role in the growth process and
has many metabolic functions, such as increasing muscle mass and
bonemineral density, and stimulates islet cell growth and insulin secre-
tion (Nielsen et al., 2001; Rhodes, 2000). Despite this, the observed ef-
fect of GH has been to counteract insulin's action and lead to insulin
resistance in insulin target tissue (Coschigano et al., 2000).
Since IGF-1-GH axis is thought to play a prominent role in glucose
tolerance and T2DM (Robertson et al., 2008; Vaessen et al., 2001), and
chronic use of alcohol reduces circulating IGF-1 levels (Nguyen et al.,
2012), we hypothesize that progression of T2DM might be inﬂuencednse.
Table 1
Body weight by group (O-C, O-E, L-C, and L-E) at baseline and after six weeks of feeding
Lieber-DeCarli diet.
Group N Weight (g)
Baseline After 6 weeks
L-C 9 275.77 ± 4.42 326.33 ± 4.48
L-E 8 273.00 ± 9.50 320.00 ± 3.78
O-C 9 278.55 ± 8.22 320.00 ± 3.00
O-E 7 300.75 ± 8.73 319.25 ± 9.28
Data were analyzed by one-way ANOVA and repeated measures ANOVA. There were no
signiﬁcant differences among the groups. O-E: OLETF-Ethanol; O-C: OLETF-Control; L-E:
LETO-Ethanol; L-C: LETO-Control.
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which may lead to aggravation of diabetes-related parameters in the
setting of alcoholism. However, the pathophysiologic mechanisms af-
fecting T2DM after alcohol ingestion are still largely unknown, and in
particular the interaction between the glucose intolerance, IGF-I and
GH remains unclear. This study was conducted to determine if chronic
heavy alcohol exposure is potentially involved in glucose homeostasis
and is mediated by alterations in IGF-I and GH, both of which have
been previously linked to an increase risk for T2DM. In addition, ex-
treme abnormalities of glucose tolerance in T2DM that occurred as a
consequence of chronic use of alcohol were also investigated.
Materials and methods
Animals
Fifty-four week-old male Otsuka Long-Evans Tokushima Fatty
(OLETF) rats and non-diabetic male Long-Evans Tokushima Otsuka
(LETO) rats were purchased from Central Lab Animal Inc. (Seoul,
Korea). The rats were divided into four groups: LETO-Control (O-C,
n = 9), LETO-Ethanol (O-E, n = 7), OLETF-Control (L-C, n = 9),
OETF-Ethanol (L-E, n = 8). The rats were maintained in a controlled
temperature (22–24 °C) with a 12 h light/dark cycle. All experi-
ments were approved by the Catholic University Animal Care and
Use Committee (CUMC-2012–0027-01). Animal care and experi-
mental procedures conformed to the National Institute of Health
Guidelines for the Care and Use of Laboratory Animals (NIH Publica-
tions No. 80–23) revised in 1996.
Diet and treatment
The rats in the alcohol-fed group received 100 mL of Lieber-DeCarli
Regular Ethanol diet (Cat. No. 710260, Dyers Inc., Bethlehem, PA) in-
cluding 36% ethanol and control rats were fed a Lieber-DeCarli control
diet (Cat. No. 710027, Dyers Inc., Bethlehem, PA) daily for six weeks,
as recommended by the manufacturer. Animals were weighted on a
weekly basis, with the goal of matching weights all groups, based on
the previous reports (Jung et al., 2011).
Intraperitoneal glucose tolerance test
IP-GTT was performed before sacriﬁcing the animals. The ani-
mals were fasted overnight (17 h) and given intraperitoneal glucose
(2 g/kg, dextrose). Blood was then taken from the tail vein, and the
glucose levels were measured using a portable glucose meter (One
Touch Ultra, Johnson & Johnson Medical, USA). The glucose level
was obtained at 0 min (fasting), 30 min, and 120 min after glucose
administration.
Measurement of serum samples
After 6 weeks of feeding Lieber-DeCarli diet, following starvation for
12 h, the animals were anesthetized with isoﬂurane (1% to 2% with
0.8 L/min O2 administrated with a facemask) and blood (3–5 mL) was
drawn directly from the heart. Samples were centrifuged at 800 ×g at
25 °C for 20 min and stored at−80 °C until the analysis was performed.
The biochemical parameters of serum were measured using a Selectra 2
auto-analyzer (Vital Scientiﬁc, Netherlands). Serum IGF-I concentrations
were determined by the RAT/MOUSE IGF-I Single Plex kit (RMIGF-
187 K, LINCO Research, St. Charles, MO, USA) and the GH levels were
measured by the Brain Derived Neurotrophic Factor Sandwich ELISA kit
(No. CYT306, Chemicon, USA). The serum insulin levels were measured
using the Rat Metabolic Magnetic Bead Plate (No. RMHMAG-84K,
Millipore, USA),Statistical analysis
The data are expressed as themean ± SEM for groups based on 7–9
rats in each group. Each experiment was repeated at least twice. Differ-
ences between groups were analyzed by analysis of variance (ANOVA)
using SPSS (Version 15.0; SPSS Inc., Chicago, IL, USA). ANOVA results
followed by Tukey's post hoc test with p b 0.05 were considered to be
statistically signiﬁcant.Results
Changes in body weight
At baseline, the body weights in the different groups ranged be-
tween 275.78 g and 300.75 g, with no statistically signiﬁcant differ-
ences among the groups (Table 1). After 6 weeks of feeding Lieber-
DeCarli diet, the body weights in the L-C (from 275.78 ± 4.41 to
326.33 ± 4.48 g) and L-E (from 273.00 ± 9.50 to 320.00 ± 3.78 g)
groups were both increased compared to baseline, but they were not
signiﬁcantly different from each other. The body weight increase in
the O-C group (from 278.55 ± 8.22 to 320.00 ± 3.00 g) was similar
to theO-E group (from 300.75 ± 8.73 to 319.25 ± 9.28 g). The average
calculated amounts of alcohol based on liquid alcohol consumption in
the L-E and O-E group were 9.35 and 9.86 g/kg/day, respectively; this
constituted heavy alcohol consumption.Changes in blood glucose concentrations
Glucose concentrations during the IP-GTT were elevated in the alco-
hol consumption groups at all time-points from 30 to 120 min (Fig. 1).
Prior to glucose injection, the mean glucose levels in the L-C, L-E, O-C,
and O-E groups were 101.22 ± 1.27, 94.28 ± 2.34, 104.44 ± 0.73, and
91.63 ± 3.13 mg/dL, respectively. The mean glucose levels in the O-E
group were signiﬁcantly lower than that of the L-C group at that time-
point (p b 0.05). Thirtyminutes after IP injection, themean glucose levels
in the L-C, L-E, O-C, and O-E groups were 139.00 ± 8.46, 181.47 ± 6.75,
255.89 ± 13.80, and285.625 ± 23.11 mg/dL, respectively; all grouphad
an increase in the mean glucose levels compared to the baseline. The in-
crease in mean glucose levels in the O-E group was signiﬁcantly greater
than that of either the L-C group (p b 0.001) or the O-C group
(p b 0.001). One hundred twenty minutes after IP injection, the mean
glucose levels in the L-C, L-E, O-C, and O-E groups were 99.44 ± 2.52,
109.14 ± 1.72, 131.44 ± 4.92, and 192.13 ± 12.36 mg/dL, respectively;
again, all group had an increase in the mean glucose levels compared to
the baseline measurement. The increase in the mean glucose levels in
the O-E group was still signiﬁcantly higher than that of the L-C
(p b 0.001) and the O-C groups (p b 0.001) at the later time-point. In
contrast, the overall glucose response in the L-C and the L-E groups was
not signiﬁcantly different at 30 min and 120 min post-glucose load, but
the increase in themean glucose levels in the L-E groupwas signiﬁcantly
higher than that in the L-C group.
Fig. 1. Comparison of IP-GTT by group (O-E, O-C, L-E, and L-C). Blood glucose levels were
measured at baseline and 30 min and 120 min after intraperitoneal glucose administra-
tion. Data were analyzed by one-way ANOVA and repeated measures ANOVA.
***p b 0.001 vs. L-C group, ###p b 0.001 vs. O-C group.
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Fig. 2A shows the mean IGF-I levels in the L-C, L-E, O-C, and O-E
groups, which were 229,888.89 ± 31,859.26, 140,142.86 ± 13,659.86,
153,844.44 ± 27,918.90, and 115,414.29 ± 9,847.93 pg/mL, respec-
tively; The mean IGF-I level in the O-E group was signiﬁcantly lower
than that in the L-C group (p b 0.05). IGF-I levels in the L-E and O-C
groups were lower than those in the L-C group but these differences
were not signiﬁcant. Fig. 2B displays that the mean GH levels in the L-
C, L-E, O-C, and O-E groups, which were 2341.25 ± 262.04,
3321.43 ± 483.89, 3037.78 ± 820.76, and 7157.50 ± 2123.52 pg/mL,
respectively; the mean GH level in the O-E group was signiﬁcantly
lower than that in the L-C group (p b 0.05). The GH levels in the L-E
and O-C groups were lower than those in the L-C group but these dif-
ferences were not statistically signiﬁcant. Fig. 2C gives the mean in-
sulin levels by group. In the L-C, L-E, O-C, and O-E groups, the mean
insulin levels were 538.9 ± 130.0, 535.7 ± 41.10, 704.6 ± 71.50,
and 265.5 ± 29.56 pg/mL, respectively. The mean insulin levels inFig. 2. Comparison of IGF-1 levels (A), GH levels (B), and insulin levels (C) by group (O-E, O-C, L-
O-C group. Vertical bars indicate the S.E.O-E group were signiﬁcantly lower than those in the L-C group and
the O-C group (p b 0.05; p b 0.01, respectively).
Correlation between levels of blood glucose and IGF-I
There was a negative correlation between blood glucose and IGF-I
levels (r = −0.54, p = 0.0305) (Fig. 3). However, serum GH levels
did not signiﬁcantly correlate with blood glucose and IGF-I levels
(r = 0.24, p = 0.2369; r = −0.22, p = 0.4224, respectively).
Discussion
Several earlier studies have focused on the effect of chronic alcohol
use on growth factors such as neurotrophins that are expressed only
in the nervous system, as well as ﬁbroblast growth factor (FGF), insulin,
and IGF-1, which are ubiquitously expressed (Sonntag and Boyd, 1989;
Yoon et al., 2006). Low circulating levels of brain-derived neurotrophic
factor (BDNF) and increased severity of insulin resistance as measured
by the homeostasis model assessment index, which is based on fasting
glucose and insulin levels, have been observed in individuals with alco-
holism (Krabbe et al., 2007). BDNF may also regulate glucose metabo-
lism to reduce food intake and lower blood glucose in the obese
diabetic mice (Nakagawa et al., 2000). Thus, the malfunction of some
of the growth/trophic factor system has been of considerable interest
given its potential contribution to the negative effects of T2DM in the
setting of chronic alcohol consumption.
In this study, alcohol-related alterations that have previously been
implicated in the pathophysiology of T2DM were observed with the IP-
GTT. The slope of the line showing plasma glucose between 30 and
120 min of the GTT in Fig. 1 shows a parallel between the diabetic and
non-diabetic rats treatedwith alcohol, suggesting that the rate of glucose
disposal might have been impaired in these animals. Ethanol treatment
diminished fasting glucose and increased postprandial glucose levels.
These effects were greater in the OLETF rats than in the LETO rats, imply-
ing that alcohol did aggravate pre-existing T2DM in the OLETF rats, but
did not, by itself, result in the presentation of T2DM in the LETO rats. It
is well known that the impaired response to insulin and β-cell failure
in the setting of alcohol-related glucose intolerance is likely importantE, and L-C). Datawere analyzed by one-wayANOVA. *p b 0.05 vs. L-C group, ## p b 0.01vs.
Fig. 3. Correlation between levels of blood glucose and IGF-1 and GH. Circulating concentrations of glucose, IGF-1, and GH detected in serum samples taken from L-C and O-E group. Rep-
resentative correlations in blood glucose are shown as a scatter-plotwith IGF-1 or GH (closed triangles = IGF-1 or GH) plotted. Datawere analyzed using Pearson's correlation coefﬁcients.
There was signiﬁcant correlation at level of 0.05 between blood glucose and changes of IGF-1 (r = −0.54).
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1993). As a result of this β-cell dysfunction and inadequate insulin re-
lease, postprandial glucose levels increase due to incomplete suppres-
sion of hepatic glucose production and decreased efﬁciency of liver and
muscle glucose uptake (Kahn, 2001;Wannamethee et al., 2002). In addi-
tion to this, continued alcoholmetabolism interferes with hepatic gluco-
neogenesis, which leads to lower blood glucose levels, as well as insulin
secretion that is also reduced as the level of blood glucose falls.
The most notable ﬁndings of the present study are that ethanol
treated OLETF rats presented signiﬁcantly lower serum IGF-I levels,
higher serum GH levels, and lower serum insulin levels than compared
to those in the non-ethanol-treated LETO rats, which suggest that the
comorbidity of alcohol dependence and T2DMmay create a synergic in-
ﬂuence in IGF-I and GH levels. Studies have consistently reported that
IGF-I deﬁciency is associatedwithdecreased insulin sensitivity and is ul-
timately linked to T2DM (Friedrich et al., 2012; McDonald et al., 2007;
Sesti et al., 2005). IGF-I is also a prominent signaling molecule in the
central nervous system (CNS), suggesting that it may have a reduced
neurotrophic inﬂuence in the brain in the setting of diabetes (Porte
et al., 2005). It has recently been suggested that IGF-I levelsmay indicate
a positive prognostic indicator in metabolic syndrome, and increases in
log-transformed IGF-I concentrations have been shown to markedly re-
duce metabolic syndrome (Sesti et al., 2005). Plasma IGF-I levels have
also been shown to be decreased in diabetes (Asplin et al., 1989). Our
ﬁndings suggest that the lower IGF-I levels in T2DM associated with al-
cohol use in this studymight be a reﬂection of the severity of themeta-
bolic disturbance. Additionally, one could speculate that oxidative
stress, which is considered to have a substantial effect on apoptosis
through the formation of lipid hydroperoxides, may result in an overall
decrease in circulating IGF-I levels. Chronic heavy alcohol use also in-
creases mitochondrial reactive oxygen species (ROS) production,
which through mitochondrial damage is one of the earliest events in
glucose intolerance. The deleterious effects of ethanol on β-cells also in-
clude an exquisite sensitivity to oxidative stress (Dembele et al., 2009).
Moreover, ROS-dependent β-cells dysfunction is thought to be involved
in glucolipotoxicity and may be associated with the progression from
metabolic syndrome to T2DM (Guichard et al., 2008).
In contrast, the effect of chronic alcohol consumption onwas to signif-
icantly increase the serum GH levels. Our result is supported by the ear-
lierﬁnding that liver-speciﬁc IGF-I gene depletedmice exhibited elevated
GH levels and impaired activation of early signaling events in response to
insulin, aligned with low plasma IGF-I. These were associated with sus-
ceptibility to severe insulin resistance and diabetes (Usui et al., 2002;
Yakar et al., 2001). Another potentialmechanism that has been described
is that where insufﬁcient negative feedback between the hypothalamus
and pituitary leads to low plasma IGF-I, causing GH hypersecretion and
reduced insulin sensitivity, especially in the skeletal muscle. The priming
effect of the GH excess generates a state of insulin resistance by impairing
the ability of insulin to inhibit glucose production and promote glucoseutilization. Furthermore, continued GH excess causes fasting hyperglyce-
mia, and subjects may develop diminished fasting insulin and an extend-
ed decline in their insulin response to a given glucose load (Colao et al.,
2004; Yakar et al., 2004). Thus, alterations in GH affect the ability to
meet metabolic demand, inﬂuencing the capacity to maintain islet β-
cell mass and adequate insulin secretion, and could present an intriguing
biological mechanism linking chronic alcohol consumption and T2DM.
In parallel with these observed changes in IGF-I and GH, serum insu-
lin levels in ethanol treated OLETF rats were signiﬁcantly lower than in
the non-ethanol treated LETO rats. Insulin is required for GH-stimulated
secretion of IGF-I from the liver. High concentrations of alcohol are con-
sidered to reduce insulin binding and suppress insulin intracellular sig-
naling, inducing a state of reversible insulin resistance. Thus, a role for
insulin has been demonstrated in several studies concerning the in-
volvement of chronic alcohol use in glucose metabolism (Singh et al.,
1988). Previous studies have described the complicated relationship be-
tween insulin and IGF-I, in that the insulin resistance associated with
chronic hyperinsulinemia may be linked to low IGF-I and GH receptor
resistance, while hypoinsulinemia may actually induce low IGF-I
(Bereket et al., 1995; Brugts et al., 2010). In concordance with previous
reports, impaired glucose tolerance was characterized not only by
changes in low IGF-I and high GH, but also by a fall in fasting insulin
(Sesti et al., 2005). The results of the present study suggest that im-
paired insulin secretion, as indicated by dysregulation of the IGF-I and
GH system, may contribute to alcohol-induced diabetes.
Most importantly, we found a strong negative correlation between
the concentrations of postprandial blood glucose and IGF-I. At the
same time, blood glucose concentrations did not signiﬁcantly correlate
with GH levels. In contrast to the primary action of GH, which lessens
glucose uptake, increases hepatic glucose production, decreases the
conversion of glucose to fat and reduces the responsiveness of target tis-
sue to insulin, several studies have addressed controversial results with
respect to GH and glucose homeostasis (Liu et al., 2004). Thus, IGF-I and
GH seem to represent the overall diabetogenic effects of chronic alcohol
consumption, but are being further investigated.
There are possible limitations in this study. One is that the impact of
chronic excessive alcohol use on hepatic gluconeogenesis in diabetic
rats, which might help to distinguish the combined effects of alcohol
and T2DM from that of alcohol or T2DM alone, was not tested and
thus needs further study. Although observations of the histological ef-
fects of chronic heavy alcohol consumption in animals with diabetes
did not ﬁgure into our study, several ﬁndings have demonstrated that
alcohol administration to diabetic rats results in more severe hepatic
damage than that observed in non-diabetic rats (Shanmugam et al.,
2011). Additionally, although the evidence suggested that IGF-1 repre-
sents a viable therapeutic target in modulating glucose dysfunction re-
lated to alcoholism, addition of more animals experimented with
strategies to increase serum IGF-1 levels could strengthen our results.
Therefore, further studies are necessary to conﬁrm these effects.
782 S.-J. Kim et al. / Life Sciences 93 (2013) 778–782In summary, we have demonstrated that in ethanol treated OLETF
rats, the serum IGF-I and insulin levels decrease, the serumGH levels in-
crease, and these changes are implicated in changes in glucose intoler-
ance. The results of the present study suggest that IGF-I and GH may
be important candidates as mediators between alcohol consumption
and T2DM, and play a broader role in the deteriorating glucose homeo-
stasis seenwith alcohol use. The present studywas not sufﬁcient to fully
understand the abnormalities of glucose metabolism in alcohol-related
T2DM, yet therapeutic strategies that increase in serum IGF-I levels may
be promising to prevent diabetogenic sequelae of alcohol dependence.
Conclusions
In conclusion, fasting serum IGF-I and GH measured may have pre-
dictive values for not only the development of glucose intolerance but
also the progression of T2DM, which are inﬂuenced by chronic alcohol
consumption. This study further clariﬁes the role of IGF-I and GH, and
provides insight into the effects of chronic alcohol use in the pathophys-
iology of T2DM.
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